Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 4 (2007), Issue 11 (November)

1. Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.
   Int J Cancer, 122(1): 57-62. [Abstract] [Full-text]
2. Risk of lung cancer following exposure to carbon black, titanium dioxide and talc: results from two case-control studies in Montreal.
   Int J Cancer, 122(1): 183-9. [Abstract] [Full-text]
3. Role of high-molecular weight tropomyosins in TGF-beta-mediated control of cell motility.
   Int J Cancer, 122(1): 78-90. [Abstract] [Full-text]
4. Aromatase expression predicts survival in women with early-stage non small cell lung cancer.
   Cancer Res, 67(21): 10484-90. [Abstract] [Full-text]
5. Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies.
   Cancer Res, 67(21): 10417-27. [Abstract] [Full-text]
6. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
   Cancer Res, 67(21): 10379-88. [Abstract] [Full-text]
7. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
   Virology, 368(2): 309-16. [Abstract] [Full-text]
8. Antitumor activity of cytokine-induced killer cells against human lung cancer.
   Int Immunopharmacol, 7(13): 1802-7. [Abstract] [Full-text]
9. Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described.
   Ann Rheum Dis, 66(12): 1672-4. [Abstract] [Full-text]
10. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Cancer Res, 67(22): 10958-65. [Abstract] [Full-text]
11. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.
    Cancer Res, 67(22): 10686-93. [Abstract] [Full-text]
12. Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
    Cancer Res, 67(22): 10647-52. [Abstract] [Full-text]
13. Pulmonary metastasectomy: a common practice based on weak evidence.
    Ann R Coll Surg Engl, 89(8): 744-8. [Abstract] [Full-text]
14. Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression.
    Am J Respir Cell Mol Biol, 37(6): 681-90. [Abstract] [Full-text]
15. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party.
    Bone Marrow Transplant, 40(11): 1045-8. [Abstract] [Full-text]
16. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.
    J Clin Oncol, 25(33): 5240-7. [Abstract] [Full-text]
17. Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer.
    J Clin Oncol, 25(33): 5233-9. [Abstract] [Full-text]
18. The evaluation of lymph node metastasis by endobronchial ultrasound-guided transbronchial needle aspiration: crucial for selection of surgical candidates with metastatic lung tumors.
    J Thorac Cardiovasc Surg, 134(6): 1485-90. [Abstract] [Full-text]
19. Primary intrapulmonary thymoma: a systematic review.
    Eur J Surg Oncol, 33(10): 1137-41. [Abstract] [Full-text]
20. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
    Eur J Surg Oncol, 33(10): 1191-8. [Abstract] [Full-text]
21. Intersession reproducibility of mass spectrometry profiles and its effect on accuracy of multivariate classification models.
    Bioinformatics, 23(22): 3065-72. [Abstract] [Full-text]
22. Pulmonary nodules: 3D volumetric measurement with multidetector CT--effect of intravenous contrast medium.
    Radiology, 245(3): 881-7. [Abstract] [Full-text]
23. Radiation dose from contemporary cardiothoracic multidetector CT protocols with an anthropomorphic female phantom: implications for cancer induction.
    Radiology, 245(3): 742-50. [Abstract] [Full-text]
24. Pulmonary nodules: Interscan variability of semiautomated volume measurements with multisection CT-- influence of inspiration level, nodule size, and segmentation performance.
    Radiology, 245(3): 888-94. [Abstract] [Full-text]
25. Determination of cadmium in whole blood and scalp hair samples of Pakistani male lung cancer patients by electrothermal atomic absorption spectrometer.
    Sci Total Environ, 389(2): 270-6. [Abstract] [Full-text]
26. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.
    Cancer Chemother Pharmacol, 61(2): 309-13. [Abstract] [Full-text]
27. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    J Natl Cancer Inst, 99(22): 1668-82. [Abstract] [Full-text]
28. Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
    AJR Am J Roentgenol, 189(6): 1407-13. [Abstract] [Full-text]
29. Dynamic contrast enhancement patterns of solitary pulmonary nodules on 3D gradient-recalled echo MRI.
    AJR Am J Roentgenol, 189(6): 1380-6. [Abstract] [Full-text]
30. Outcomes in octogenarians undergoing high-risk cancer operation: a national study.
    J Am Coll Surg, 205(6): 729-34. [Abstract] [Full-text]
31. Respiratory-gated helical computed tomography of lung: reproducibility of small volumes in an ex vivo model.
    Int J Radiat Oncol Biol Phys, 69(5): 1642-9. [Abstract] [Full-text]
32. Cone-beam CT localization of internal target volumes for stereotactic body radiotherapy of lung lesions.
    Int J Radiat Oncol Biol Phys, 69(5): 1618-24. [Abstract] [Full-text]
33. On-line target position localization in the presence of respiration: a comparison of two methods.
    Int J Radiat Oncol Biol Phys, 69(5): 1634-41. [Abstract] [Full-text]
34. Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning.
    Int J Radiat Oncol Biol Phys, 69(5): 1402-8. [Abstract] [Full-text]
35. An approach for practical multiobjective IMRT treatment planning.
    Int J Radiat Oncol Biol Phys, 69(5): 1600-7. [Abstract] [Full-text]
36. What do patients want from their radiation oncologist? Initial results from a prospective trial.
    Int J Radiat Oncol Biol Phys, 69(5): 1527-33. [Abstract] [Full-text]
37. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.
    Int J Radiat Oncol Biol Phys, 69(5): 1409-16. [Abstract] [Full-text]
38. Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 69(5): 1534-43. [Abstract] [Full-text]
39. Quantification of motion of different thoracic locations using four-dimensional computed tomography: implications for radiotherapy planning.
    Int J Radiat Oncol Biol Phys, 69(5): 1395-401. [Abstract] [Full-text]
40. Readmission to intensive care unit after initial recovery from major thoracic oncology surgery.
    Ann Thorac Surg, 84(6): 1838-46; discussion 1838-46. [Abstract] [Full-text]
41. Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved?
    Ann Thorac Surg, 84(6): 1830-6. [Abstract] [Full-text]
42. Effect of formalin fixation on tumor size determination in stage I non-small cell lung cancer.
    Ann Thorac Surg, 84(6): 1825-9. [Abstract] [Full-text]
43. Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases.
    Ann Thorac Surg, 84(6): 1818-24. [Abstract] [Full-text]
44. Long-term outcome of surgical treatment for non-small cell lung cancer with comorbid liver cirrhosis.
    Ann Thorac Surg, 84(6): 1810-7. [Abstract] [Full-text]
45. Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer.
    Biochem Biophys Res Commun, 365(2): 221-6. [Abstract] [Full-text]
46. The value of medical interventions for lung cancer in the elderly: results from SEER-CMHSF.
    Cancer, 110(11): 2511-8. [Abstract] [Full-text]
47. Computed tomography screening for lung cancer: review of screening principles and update on current status.
    Cancer, 110(11): 2370-84. [Abstract] [Full-text]
48. A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
    Cancer, 110(11): 2502-6. [Abstract] [Full-text]
49. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations.
    Cancer, 110(11): 2507-10. [Abstract] [Full-text]
50. Treatment of metastatic sialoblastoma with chemotherapy and surgery.
    Pediatr Blood Cancer, 50(1): 134-7. [Abstract] [Full-text]
51. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000.
    Am J Epidemiol, 166(12): 1381-91. [Abstract] [Full-text]
52. Reconstruction of the right atrium with pulmonary artery homograft after resection of right atrial lipomatosis.
    Interact Cardiovasc Thorac Surg, 6(6): 826-7. [Abstract] [Full-text]
53. Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis.
    Interact Cardiovasc Thorac Surg, 6(6): 720-30. [Abstract] [Full-text]
54. Lung cancer resection rate in south Manchester: is it comparable to international standards? Results of a prospective tracking study.
    Interact Cardiovasc Thorac Surg, 6(6): 712-4. [Abstract] [Full-text]
55. Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.
    J Clin Oncol, 25(34): 5381-9. [Abstract] [Full-text]
56. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy.
    J Clin Oncol, 25(34): 5374-80. [Abstract] [Full-text]
57. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    J Clin Oncol, 25(34): 5506-18. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.